BPC-157 пептид 10мг

BPC157 – Изследователски пептид за метаболитни проучвания и проучвания за регулация на теглото

---

Употреба на продукта: Всички продукти, предлагани на този уебсайт, са предназначени изключително за изследователски и развойни цели и строго не са за човешка консумация или терапевтична употреба. Тези продукти не са одобрени от Американската администрация по храните и лекарствата (FDA), а никое твърдение на този уебсайт не е било оценявано от FDA. Продуктите и предоставената информация не са предназначени за диагностика, лечение, излекуване или превенция на каквото и да е заболяване или медицинско състояние.

Our research-grade GLP-RT (Retatrutide) is a novel multi-agonist peptide currently under investigation for its broad metabolic and weight-regulation potential. Retatrutide is a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, making it a promising candidate for studies in obesity, glucose control, insulin resistance, and energy expenditure.

Potential Research Benefits:

• Multi-Pathway Metabolic Activation: Combines GLP-1, GIP, and glucagon receptor agonism to support appetite regulation, fat loss, and improved energy balance in metabolic models.
• Weight Management Studies: Early research in preclinical and clinical models shows significant reductions in body weight and BMI with consistent administration.
• Glucose and Insulin Sensitivity: Enhances glucose-dependent insulin secretion while reducing postprandial glucose spikes, relevant for type 2 diabetes and insulin resistance studies.
• Increased Energy Expenditure: Glucagon receptor activation may promote lipolysis and increased resting metabolic rate.
• Liver and Cardiovascular Biomarkers: Emerging studies explore potential downstream benefits in hepatic fat reduction and cardiometabolic health markers.

Clinical Research References:

• Retatrutide is currently being investigated in clinical trials for obesity, type 2 diabetes, and related metabolic disorders due to its multi-receptor activation mechanism.

Storage and Handling:

• Store at 2–8°C (35–46°F) in a refrigerated environment.
• Protect from light and moisture.
• After reconstitution with bacteriostatic water, store refrigerated and use within 4–6 weeks for maximum integrity.

Disclaimer:

This product is intended strictly for research purposes only. Not for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with applicable laws and regulations.